Sinovac Biotech (SVA) Non-Current Deferred Tax Liability (2009 - 2026)
Sinovac Biotech's Non-Current Deferred Tax Liability came in at $335.87 million for Q2 2026, down 14.3% from $392.04 million a year earlier.
Powered by 
Analysis
Sinovac Biotech (SVA) Non-Current Deferred Tax Liability (2009 - 2026) Analysis & Trends
At the end of FY2025, Sinovac Biotech's Non-Current Deferred Tax Liability was $325.07 million, down 20.7% from FY2024.
- Non-Current Deferred Tax Liability has declined in each of the last four years, though with a five-year compound annual growth rate of 160.2% (FY2020 to FY2025).
- Going back by year, Non-Current Deferred Tax Liability was $410.05 million in FY2024 (-9.7%), $453.92 million in FY2023 (-1.8%), $462.1 million in FY2022 (-14.5%) and $540.73 million in FY2021.
- The five-year range for quarterly Non-Current Deferred Tax Liability is $239.03 million (Q2 2023) to $540.73 million (Q4 2021).
- Year-over-year, Non-Current Deferred Tax Liability increased in 1 of the last four quarters, with an average decline of 10.9%.
- The fastest year-over-year change in Non-Current Deferred Tax Liability over five years came in Q2 2022 (growth of 480.7%), and the weakest in Q2 2023 (a decline of 26.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Sinovac Biotech | 464.94 Mn | -24.98 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 335.87 Mn |
| Dec 31, 2025 | 325.07 Mn |
| Jun 30, 2025 | 392.04 Mn |
| Dec 31, 2024 | 410.05 Mn |
| Jun 30, 2024 | 387.04 Mn |
| Dec 31, 2023 | 453.92 Mn |
| Jun 30, 2023 | 239.03 Mn |
| Dec 31, 2022 | 462.10 Mn |
| Jun 30, 2022 | 325.92 Mn |
| Dec 31, 2021 | 540.73 Mn |
| Jun 30, 2021 | 56.13 Mn |
| Dec 31, 2020 | 2.72 Mn |
| Sep 30, 2011 | 335,619.00 |
| Jun 30, 2011 | 375,272.00 |
| Mar 31, 2011 | 266,016.00 |
| Dec 31, 2010 | 1.01 Mn |
| Sep 30, 2010 | 1.25 Mn |
| Jun 30, 2010 | 1.17 Mn |
| Mar 31, 2010 | 1.84 Mn |
| Dec 31, 2009 | 1.40 Mn |
API Access
Sinovac Biotech Non-Current Deferred Tax Liability API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=SVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deferred-tax-liability", "ticker": "SVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=SVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();